Novavax faces delisting threat following failed drug trial

Washington Business Journal

Apr 15, 2019

Nasdaq has warned Novavax Inc. that its stock could be delisted if it can't get the price consistently above a buck within the next six months. The Gaithersburg biotech's stock has…